Inventor · disambiguated record
Peter Diederik Jan Grootenhuis
Also filed as: GROOTENHUIS PETER · GROOTENHUIS PETER D J · GROOTENHUIS PETER DIEDERIK JAN
74 granted patents·38 pending applications·3,012 citations·filing 1997–2024
99Inventor score
Top patents by PatentIndex Score
112 records- 0199US10022352B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2016·Granted Jul 17, 2018·30 cites·20 claims
- 0299US9216969B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Dec 22, 2015·56 cites·1 claims
- 0399US8952049B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Feb 10, 2015·62 cites·3 claims
- 0499US8012999B2Modulators of CFTRVERTEX PHARMA·Filed 2010·Granted Sep 6, 2011·109 cites·20 claims
- 0599US7645789B2Indole derivatives as CFTR modulatorsVERTEX PHARMA·Filed 2007·Granted Jan 12, 2010·171 cites·3 claims
- 0698US10987348B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2018·Granted Apr 27, 2021·13 cites·6 claims
- 0798US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0898US9974781B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2016·Granted May 22, 2018·30 cites·3 claims
- 0998US8952050B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Feb 10, 2015·62 cites·23 claims
- 1098US8889875B2Pyridyl derivatives as CFTR modulatorsVERTEX PHARMA·Filed 2013·Granted Nov 18, 2014·62 cites·26 claims
- 1198US8846753B2Modulators of ATP-binding cassette transportersHADIDA RUAH SARA S·Filed 2013·Granted Sep 30, 2014·65 cites·10 claims
- 1298US8796308B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Aug 5, 2014·73 cites·4 claims
- 1398US8765957B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2013·Granted Jul 1, 2014·73 cites·3 claims
- 1498US8722704B2Modulators of ATP-binding cassette-transportersVERTEX PHARMA·Filed 2013·Granted May 13, 2014·67 cites·6 claims
- 1598US8623905B2Modulators of ATP-binding cassette transportersRUAH SARA S HADIDA·Filed 2010·Granted Jan 7, 2014·71 cites·57 claims
- 1698US8524910B2Pyridyl derivatives as CFTR modulatorsHADIDA RUAH SARA·Filed 2012·Granted Sep 3, 2013·77 cites·29 claims
- 1798US8431605B2Modulators of ATP-binding cassette transportersHADIDA RUAH SARA S·Filed 2011·Granted Apr 30, 2013·83 cites·16 claims
- 1898US8415387B2Modulators of ATP-binding cassette transportersRUAH SARA S HADIDA·Filed 2009·Granted Apr 9, 2013·83 cites·3 claims
- 1998US8324242B2Modulators of ATP-binding cassette transportersRUAH SARA HADIDA·Filed 2009·Granted Dec 4, 2012·107 cites·4 claims
- 2098US8318733B2Modulators of ATP-binding cassette transportersHADIDA-RUAH SARA SABINA·Filed 2011·Granted Nov 27, 2012·93 cites·44 claims
- 2198US8227615B2Pyridyl derivatives as CFTR modulatorsHADIDA-RUAH SARA·Filed 2009·Granted Jul 24, 2012·103 cites·3 claims
- 2298US7977322B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2005·Granted Jul 12, 2011·117 cites·34 claims
- 2398US7754739B2Modulators of CFTRVERTEX PHARMA·Filed 2008·Granted Jul 13, 2010·135 cites·27 claims
- 2497US11591350B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Feb 28, 2023·7 cites·27 claims
- 2597US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 2697US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 2797US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 2897US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 2997US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 3097US9751839B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2016·Granted Sep 5, 2017·41 cites·3 claims
- 3197US9371287B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2014·Granted Jun 21, 2016·55 cites·29 claims
- 3297US8969386B2Modulators of CFTRHADIDA-RUAH SARA·Filed 2008·Granted Mar 3, 2015·62 cites·7 claims
- 3397US8835639B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2012·Granted Sep 16, 2014·72 cites·28 claims
- 3497US8541453B2Modulators of ATP-binding cassette transportersHADIDA-RUAH SARA SABINA·Filed 2011·Granted Sep 24, 2013·74 cites·33 claims
- 3597US8507524B2Modulators of ATP-binding cassette-transportersRUAH SARA S HADIDA·Filed 2008·Granted Aug 13, 2013·74 cites·3 claims
- 3696US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 3796US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 3896US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 3996US9725440B2Modulators of CFTRVERTEX PHARMA·Filed 2015·Granted Aug 8, 2017·29 cites·7 claims
- 4096US9550761B2Modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2013·Granted Jan 24, 2017·43 cites·31 claims
- 4196US8614325B2Modulators of cystic fibrosis transmembrane conductance regulatorYANG XIAOQING·Filed 2011·Granted Dec 24, 2013·74 cites·12 claims
- 4296US8476442B2Process for making modulators of cystic fibrosis transmembrane conductance regulatorDEMATTEI JOHN·Filed 2010·Granted Jul 2, 2013·89 cites·13 claims
- 4396US8232302B2Thiazoles and oxazoles useful as modulators of ATP-binding cassette transportersMILLER MARK THOMAS·Filed 2010·Granted Jul 31, 2012·96 cites·47 claims
- 4496US7846951B2Thiazoles and oxazoles useful as modulators of ATP-binding cassette transportersVERTEX PHARMA·Filed 2008·Granted Dec 7, 2010·147 cites·44 claims
- 4595US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 4695US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 4794US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 4894US8802700B2Modulators of ATP-Binding Cassette transportersSHETH URVI·Filed 2012·Granted Aug 12, 2014·74 cites·5 claims
- 4994US7846954B2Heterocyclic derivatives as modulators of ion channelsVERTEX PHARMA·Filed 2009·Granted Dec 7, 2010·27 cites·25 claims
- 5093US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
Showing the top 50 of 112 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Diederik Jan Grootenhuis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →